Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQ93C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,325
Award facts
- Contract value 100% obligated
- $21,325.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,325.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Tagrisso 80 mg tablets, with an ultimate completion date of October 20, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical supply vehicle valued through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems.
This award is representative of AmerisourceBergen's substantial role within DLA's Medical Supply Chain, where the company fulfills recurring delivery orders across multiple therapeutic domains. Tagrisso, an oncology medication, exemplifies the specialized pharmaceutical products the company provides through its IDC vehicle to support Defense Health Agency operations and other federal healthcare systems. The delivery order structure allows DLA to procure specific quantities of pre-negotiated pharmaceutical products on an as-needed basis, demonstrating the efficiency of the underlying IDC framework in meeting military healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FQ93C?
SPE2DB25FQ93C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ93C worth?
The government has obligated $21,325 on SPE2DB25FQ93C.
Is contract SPE2DB25FQ93C an order under another contract?
Yes. SPE2DB25FQ93C is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ93C competed?
The extent of competition for SPE2DB25FQ93C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award